Evidence map›Paper›PMID 39937281›Full record

Trial reportWorld journal of urology2025

A prospective survey evaluating the visual quality of KARL STORZ fiberoptic, digital, and disposable flexible ureteroscopes.

Clarissa Wong, Perry Xu, Nicholas Dean, Mark Assmus, Alyssa McDonald, Deepak Agarwal, Sohrab Ali, Garen Abedi, Ezra Margolin, Robert Medairos and 2 more

Registry-linked trialAbstract readRandomized Controlled TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05646069 (Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05646069 nacompletednot on this map

Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi

TypeinterventionalSponsorNorthwestern UniversityRan2022 to 2023Enrolled6ConditionsUTI, Stone, KidneyArmsStorz Flex-XC1 Disposable Flexible Ureteroscope, Storz Flexible Digital Ureteroscope
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Clarissa WongDepartment of Urology, Northwestern University, 676 N St. Clair, Suite 2300, Chicago, IL, 60611, USA. Clarissa.wong@northwestern.edu.
Perry XuDepartment of Urology, Northwestern University, 676 N St. Clair, Suite 2300, Chicago, IL, 60611, USA.
Nicholas DeanDivision of Urology, University of Alberta, Edmonton, AB, Canada.
Mark AssmusDivision of Urology, University of Calgary, Calgary, AB, Canada.
Alyssa McDonaldDepartment of Urology, Northwestern University, 676 N St. Clair, Suite 2300, Chicago, IL, 60611, USA.
Deepak AgarwalDepartment of Urology, University of Minnesota, Minneapolis, MN, USA.
Sohrab AliDepartment of Urology, University of California Irvine, Irvine, CA, USA.
Garen AbediDepartment of Urology, University of California Irvine, Irvine, CA, USA.
Ezra MargolinDepartment of Urology, Duke University, Durham, NC, USA.
Robert MedairosDepartment of Urology, Duke University, Durham, NC, USA.
Charles NottinghamDepartment of Urology, Washington University in St. Louis, St. Louis, MO, USA.
Amy KrambeckDepartment of Urology, Northwestern University, 676 N St. Clair, Suite 2300, Chicago, IL, 60611, USA.

Funding

KARL STORZ, El Segundo, CA AWD00001545
6 · The paper itself

Abstract

purposeTo compare the visual quality amongst the disposable FLEX-XC1, digital FLEX-XC, and fiberoptic FLEX-X2S flexible ureteroscopes (FUS) and determine whether urologists can distinguish which FUS is in use.

methodsIn this prospective survey, 6 patients were prospectively randomized to the disposable FLEX-XC1, digital FLEX-XC, and fiberoptic FLEX-X2S FUS for retrograde intrarenal surgery (RIRS) for nephrolithiasis. Each RIRS was performed by a single-surgeon and recorded. 9 fellowship-trained endourologists were blinded to which FUS was used. They were asked to view the recordings, answer which FUS was used, and fill out a 7-question survey grading parameters from 0 to 5. Statistical analysis was performed with SPSS. ANOVA with Tukey's posthoc analysis confirmed significance defined as p < 0.05.

results78%, 89%, and 78% of endourologists correctly identified which FUS was used between the disposable FLEX-XC1, digital FLEX-XC, and fiberoptic FLEX-X2S FUS's respectively. The digital FUS outperformed the others in overall score (p < 0.001). The only visual parameter that was not statistically different amongst FUS's was Laser Activation Interference (p = 0.97). After Tukey's posthoc analysis, the digital FUS outperformed the fiberoptic scope in all parameters except LAI. The disposable FUS outperformed the fiberoptic scope in all parameters except for LAI, tissue interference (TI), and overall impression. The digital FUS was superior to the disposable FUS only in Visual quality (Color) and TI.

conclusionsThe majority of fellowship-trained endourologists can distinguish which type of KARL STORZ FUS is in use. The KARL STORZ digital and disposable FUS's outperform the KARL STORZ fiberoptic FUS in nearly all visual parameters. The KARL STORZ disposable FUS is comparable to the KARL STORZ digital FUS except for Visual Quality (Color) and Tissue Interference. CLINICAL

trial registrationThis study was approved by the Northwestern Institutional Review Board and was assigned study ID STU00217933. It is also registered under NCT05646069, titled "Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi."

Indexed as

Disposable EquipmentKidney CalculiUreteroscopesUreteroscopyEquipment DesignFemaleFiber Optic TechnologyHumansMaleProspective StudiesFlexible ureteroscopeLaser activation interferenceRetrograde intrarenal surgeryVisual quality

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.